Literature DB >> 21636544

Biomarkers in exploring the frontiers of diagnosis, prognosis, and therapy of Barrett's esophagus.

Patrick Yachimski1, Richard M Peek.   

Abstract

Barrett's esophagus (BE) is the principal risk factor for esophageal adenocarcinoma. BE patients currently undergo periodic endoscopic surveillance with tissue sampling and histopathologic assessment for dysplasia. They frequently are prescribed proton pump inhibitors to pharmacologically suppress gastric acid that is the cause of BE. These standard endoscopic and pharmacologic approaches for managing BE are crude at best. Identification of novel tissue biomarkers within BE may allow for more accurate endoscopic risk stratification and provide potential targets for chemoprevention.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21636544      PMCID： PMC3174469          DOI： 10.1158/1940-6207.CAPR-11-0204

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN： 1940-6215


  30 in total

Review 1.  Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

Authors:  N J Shaheen; M A Crosby; E M Bozymski; R S Sandler
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

2.  Evaluation of difluoromethylornithine for the chemoprevention of Barrett's esophagus and mucosal dysplasia.

Authors:  Frank A Sinicrope; Russell Broaddus; Nina Joshi; Eugene Gerner; Elizabeth Half; Ilan Kirsch; Jan Lewin; Bruce Morlan; Waun Ki Hong
Journal:  Cancer Prev Res (Phila)       Date:  2011-06

3.  A national study of Helicobactor pylori infection in gastric biopsy specimens.

Authors:  Amnon Sonnenberg; Richard H Lash; Robert M Genta
Journal:  Gastroenterology       Date:  2010-08-19       Impact factor: 22.682

4.  Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.

Authors:  C D Morris; G R Armstrong; G Bigley; H Green; S E Attwood
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

5.  Cyclooxygenase-2 expression in esophageal epithelium before and after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.

Authors:  Patrick Yachimski; Mari Mino-Kenudson; Margaret E Sherwood; William P Puricelli; Norman S Nishioka; Gregory Y Lauwers
Journal:  Virchows Arch       Date:  2011-11-13       Impact factor: 4.064

6.  Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated.

Authors:  Wouter L Curvers; Fiebo J ten Kate; Kausilia K Krishnadath; Mike Visser; Brenda Elzer; Lubertus C Baak; Clarisse Bohmer; Rosalie C Mallant-Hent; Arnout van Oijen; Anton H Naber; Pieter Scholten; Olivier R Busch; Harriët G T Blaauwgeers; Gerrit A Meijer; Jacques J G H M Bergman
Journal:  Am J Gastroenterol       Date:  2010-05-11       Impact factor: 10.864

Review 7.  Barrett's esophagus.

Authors:  Gary W Falk
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

8.  High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.

Authors:  Denis Chatelain; Jean-François Fléjou
Journal:  Virchows Arch       Date:  2002-09-24       Impact factor: 4.064

9.  Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus.

Authors:  Christianne J Buskens; Bastiaan P Van Rees; Anna Sivula; Johannes B Reitsma; Caj Haglund; Piter J Bosma; G Johan A Offerhaus; J Jan B Van Lanschot; Ari Ristimäki
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

10.  Helicobacter pylori and esophageal disease: wake-up call?

Authors:  Martin J Blaser
Journal:  Gastroenterology       Date:  2010-10-26       Impact factor: 22.682
View more
  1 in total

1.  Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus.

Authors:  Daniela Cabibi; Stefano Caruso; Viviana Bazan; Marta Castiglia; Giuseppe Bronte; Sabrina Ingrao; Daniele Fanale; Antonina Cangemi; Valentina Calò; Angela Listì; Lorena Incorvaia; Antonio Galvano; Gianni Pantuso; Eugenio Fiorentino; Sergio Castorina; Antonio Russo
Journal:  Oncotarget       Date:  2016-07-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.